SEC Form 4 · accession 0000899243-15-002011
Ocugen, Inc. · OCGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gloria Matthews
Officer — Chief Medical Officer
Period of report
Jul 29, 2015
Accepted (ET)
Jul 31, 2015 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.11 | Jul 29, 2015 | A | 120,000 | A | — | Jul 29, 2025 | Common Stock | 120,000 | 120,000 | D |
| Employee Stock Option (Right to Buy)F2 | $6.11 | Jul 29, 2015 | A | 30,000 | A | — | Jul 29, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option vests over four (4) years of continuous service following July 14, 2015, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and the balance vesting in thirty-six (36) equal monthly installments thereafter.
- F2This option shall vest in full if the Issuer's Common Stock price reaches $19.92 per shares or above for any consecutive sixty (60) day period within four (4) years of the date of grant (the date such option vests, the "Vesting Date"). In addition, if this option is exercised within one (1) year of the Vesting Date, the Reporting Person must hold shares (net of taxes) until the one (1) year anniversary of the Vesting Date.